Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic HypersensitivityJohn P. Russell, Beverley Greenwood–Van Meerveld, Yuhong Shen et al.|Journal of Pharmacology and Experimental Therapeutics|2018Cited by 15
Abstract 4714: Preclinical evaluation of a novel LSD1 inhibitor SYHA1807 for the treatment of small cell lung cancerLingyun Wu, Shuhui Chen, Hanyu Yang et al.|Cancer Research|2019Cited by 3
Abstract 1970: Preclinical candidate TQB3824, a small molecule inhibitor of CDC7, shows strong antitumor efficacy in colorectal and pancreatic tumor modelsGang Li, Shu‐Hui Chen, Charles Z. Ding et al.|Cancer Research|2021Cited by 2